Mario Gabelli Neuronetics, Inc. Transaction History
Gamco Investors, Inc. Et Al
- $8.37 Billion
- Q1 2025
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 77,200 shares of STIM stock, worth $297,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,200
Previous 77,900
0.9%
Holding current value
$297,220
Previous $116,000
144.83%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding STIM
# of Institutions
109Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$8.88 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.69 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$5.46 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.24 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.85 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $104M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...